| When good burps go bad
It's totally freaky, but if you always thought heartburn was just heartburn, you may be in for a surprise. Most of the time it is, but for some folks it's really gastroesophageal reflux disease (GERD), a really annoying condition that can potentially lead to other scary illnesses like asthma, lung infection, inflammation of the esophagus and even cancer. GERD is caused by the reflux of stomach contents back into the esophagus, and when those are high in acid it becomes a more serious problem. Once you get GERD, many say, it usually becomes a lifelong problem, meaning you will need treatment for the rest of your life. Is that so? .
Many stomach cancer cases caused by tobacco use
ISLAMABAD: Cigarette smoking and use of other tobacco products significantly increases the risk of death from stomach cancer in men and women, a large study of US adults indicates. Stomach cancer is the second most common cancer worldwide and is known to be linked to chronic infection with the ulcer-causing bacteria Helicobacter pylori. In its Review of Tobacco conducted in June of this year, the International Agency for Research on Cancer concluded that there is "sufficient evidence in humans" to infer a causal relationship between stomach cancer and tobacco use, says Dr. Ann Chao of the American Cancer Society in Atlanta, Georgia. Chao's group examined stomach cancer mortality in relation to cigarette smoking in women and cigarette, cigar, pipe and smokeless tobacco use in men enrolled in the Cancer Prevention II Study.
New Analysis Shows That Intensive Lipitor Therapy Cuts the Risk of ...
NEW YORK, Feb. 7 /PRNewswire-FirstCall/ -- Patients with coronary heart disease who took Lipitor(R) (atorvastatin calcium) 80 mg tablets reduced their risk of hospitalizations due to heart failure compared to patients taking the 10 mg dose of Lipitor, according to a new analysis of a subset of patients from the five-year TNT (Treating to New Targets) study, published in today's issue of Circulation. "These results show that patients with a history of heart failure who were treated with Lipitor 80 mg dose significantly reduced their chances of hospitalizations for heart failure," said Dr. Rochelle Chaiken, vice president of Pfizer's CV Metabolic group. "This important new information for physicians and patients adds to what has been shown about the cardiovascular efficacy of Lipitor in reducing the risk of events like heart attacks, strokes and revascularization procedures." The analysis showed that patients with heart disease who took Lipitor 80 mg dose achieved significant reductions in the risk of hospitalizations due to heart failure by 26 percent.
|
